Chairman, California Institute for Regenerative Medicine (CIRM)
Jonathan Thomas, Ph.D., J.D., is the Chair of the governing Board of California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM). As Chair he is responsible for helping guide the funding decisions of the agency’s 29 member Board, charged with distributing $3 billion to fund the development of stem cell therapies and cures for people in need.
JT’s interest in science is a long-running one. He majored in Biology and History at Yale. As a George C. Marshall Scholar at Oxford, he then earned a PhD with a medical focus in Commonwealth History before returning to Yale Law School.
His career has spanned finance, the law and politics. Before joining CIRM he was a Co-Founding Partner at Saybrook, an investment banking and private equity firm based in Santa Monica, California. His legal experience includes clerking for White House Counsel Lloyd Cutler in the last year of the Carter Administration. He has also served on a number of Boards working closely with political officials at the federal, state and local level on a variety of projects for over 25 years
JT also has a long-standing commitment to patient advocacy, serving more than 15 years on the Board AbilityFirst, which assists children with spinal cord injuries and mental disabilities that could be targets of stem cell therapies.
The opening panel discussion will give an overview of the state of the gene therapy, cancer immunotherapy, and regenerative medicine fields. Alliance for Regenerative Medicine’s Chair, Dr. Robert Preti, will moderate the panel of industry and research experts.